European Association for the Study of the Liver Apps

ILC 2019 is the official delegates' app of EASL’s The InternationalLiver Congress™2019 in Vienna. It offers you a more meaningful wayto experience the event. With the app you have full access to thescientific programme, posters and abstracts of the congress as wellas maps of the halls and exhibitor stands. It lets you see who isattending, search the entire programme and actively contribute tosessions with the congress interaction tools. Before you use theapp for the first time it will download the latest congress data.After that, you can use the app without an internet connection,though programme updates will be available before and during theCongress. This app is provided by EASL (European Association forthe Study of the Liver).

EASL – The Home of Hepatology – is Europe’s preeminentliverassociation with global reach and influence. SCIENTIFICEVENTSEducation is a priority for EASL and the associationprovideseducational opportunities at every level from clinicalfellow toprofessor. Every year, EASL hosts: - The InternationalLiverCongress™, the annual meeting of the association, unitingover10,000 liver experts - 1 EASL Special Conference withsponsorshipopportunities for those interested in Hepatology - Up to3 EASLMonothematic Conferences - 3 Schools of Hepatology (1 basicscienceand 2 clinical courses) dedicated to young investigators -Everyother year, 1 HCC Summit combining both basic science andclinicalresearch - A series of ‘Best of EASL’ events around theglobe - 1EASL Masterclass dedicated to young investigators - EASLalsoendorses other liver related conferences, and sponsors eventsinthe field. EASL, The European Association for the Study oftheLiver, was founded in 1966 and has now grown from asmallorganisation that hosted 70 participants at its first meetingtoconsistently welcoming over 10,000 delegates to itsannualCongress. EASL attracts hepatology experts and key opinionleadersas members and has an impressive track record inpromotingresearch, supporting education, and advocating for EU-widepolicychange on liver disease.